1
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition(s):Polycystic Kidney DiseaseLast Updated:December 1, 2016Completed
Niacinamide as an Intervention: 530 Clinical Trials, Page 1 of 53
Hide Studies Not Open or Pending
2
Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition(s):Polycystic Kidney DiseaseLast Updated:February 11, 2019Completed
3
Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus
Condition(s):Cutaneous Lupus Erythematosus; Systemic Lupus Erythematosus RashLast Updated:February 2, 2021Active, not recruiting
4
Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients
Condition(s):Mitochondrial MyopathiesLast Updated:June 4, 2019Completed
5
Study of Niacin in Glioblastoma
Condition(s):Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeLast Updated:June 22, 2021Recruiting
6
Study of Nicotinamide in Early Onset Preeclampsia
Condition(s):PreeclampsiaLast Updated:September 13, 2021Completed
7
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:January 22, 2020Completed
8
Short-term Effect of Extended-release Niacin on Endothelial Function.
Condition(s):HypoalphalipoproteinemiaLast Updated:September 13, 2013Completed
9
Nicotinamide as an Early Alzheimer’s Disease Treatment
Condition(s):Alzheimer’s Disease; Mild Cognitive ImpairmentLast Updated:November 16, 2021Active, not recruiting
10
Phase I Study of Nicotinamide for Early Onset Preeclampsia
Condition(s):Pregnancy Induced Hypertension; Superimposed Preeclampsia; HypertensionLast Updated:November 2, 2018Completed